April 2025
1. RADIC L, Offersgaard A, Kadava T, Zon I, et al
   Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein.
   Proc Natl Acad Sci U S A. 2025;122:e2420402122.
   

   >> Share

   
   March 2025
2. SARWAR S, Randall G
   HCV NS3/4A protease relocalizes CCTalpha to viral replication sites, enhancing phosphatidylcholine synthesis and viral replication.
   Proc Natl Acad Sci U S A. 2025;122:e2419632122.
   

   >> Share

   
   June 2024
3. HAMMEL A, Cucos LM, Caras I, Ionescu I, et al
   The red alga Porphyridium as a host for molecular farming: Efficient production of immunologically active hepatitis C virus glycoprotein.
   Proc Natl Acad Sci U S A. 2024;121:e2400145121.
   

   >> Share

   
   April 2024
4. PAPINI C, Ullah I, Ranjan AP, Zhang S, et al
   Proof-of-concept studies with a computationally designed M(pro) inhibitor as a synergistic combination regimen alternative to Paxlovid.
   Proc Natl Acad Sci U S A. 2024;121:e2320713121.
   

   >> Share

   
   February 2024
5. KOONIN EV
   Circular RNAs from linear viral RNA genomes: A distinct dimension in the virus world.
   Proc Natl Acad Sci U S A. 2024;121:e2401335121.
   

   >> Share

   
   
6. CAO QM, Boonchuen P, Chen TC, Lei S, et al
   Virus-derived circular RNAs populate hepatitis C virus-infected cells.
   Proc Natl Acad Sci U S A. 2024;121:e2313002121.
   

   >> Share

   
   June 2023
7. MOSA AI, Campo DS, Khudyakov Y, AbouHaidar MG, et al
   Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus.
   Proc Natl Acad Sci U S A. 2023;120:e2220294120.
   

   >> Share

   
   March 2021
8. RASCHE A, Lehmann F, Goldmann N, Nagel M, et al
   A hepatitis B virus causes chronic infections in equids worldwide.
   Proc Natl Acad Sci U S A. 2021;118:e2013982118.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share